Pharma News

Sanofi, Cipla announce exclusive distribution partnership of CNS product

Sanofi India Limited and Cipla Limited have announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium®, a leading brand in the anti-epileptic medication category. 

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage its capabilities and robust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programs to expand access to these treatments for patients who need them.

Medlarge

Recent Posts

World Homoeopathy Day 2025: Symposium to expand avenues of ‘Gentle Therapeutic System’

As an ode to Dr. Samuel Hahnemann, the founder of homoeopathy, on his birth-anniversary on…

18 hours ago

RJD chief Lalu Yadav admitted at AIIMS

RJD president and former Bihar chief minister Lalu Prasad was on Wednesday taken to Delhi…

2 days ago

EVOLVE 2025 held to discuss advancements in extracellular vesicle (EV) research in AIIMS

The Indian Society for Extracellular Vesicles (InSEV) successfully hosted its inaugural conference, EVOLVE 2025, from…

2 days ago

Brain dead saves multiple lives

A 46-year-old woman who was declared brain dead saved multiple people by donating her organs…

3 days ago

After Brain Rot, Reels now emerges as major threat for eyes: Heath experts

Following concerns about the impact of short-form videos on mental health, doctors are now raising…

3 days ago

Dr. Girish Tyagi takes charge as Delhi Medical Association President

Dr. Girish Tyagi has officially assumed the role of President of the Delhi Medical Association…

4 days ago